How did DARE's Q1 2024 EPS surprise the market?
4/3/2025 11:13am
Dare Bioscience's (DARE) Q1 2024 EPS fell short of market expectations, with a reported diluted EPS of -$0.07, indicating a negative earnings surprise of -0.01. This suggests that the company's performance for the period was below what investors had anticipated, potentially impacting investor sentiment and market perception of the company's financial health.
|code|Ticker|Name|Date|EPS Surprise|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|DARE|DARE.O|Dare Bioscience|2023 Q2|0|-1.22|186|
|DARE|DARE.O|Dare Bioscience|2023 Q3|0.01|-1.09|186|
|DARE|DARE.O|Dare Bioscience|2024 Q1|-0.01|-0.07|186|